Castle Biosciences (CSTL) PT Raised to $31 at Baird, Remains Top Idea
Tweet
Share
E-mailGet Alerts CSTL Hot Sheet
Price: $29.62 --0%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
Baird analyst Catherine Schulte raised the price target on Castle Biosciences (NASDAQ: CSTL) to $31.00 (from $27.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- RCM Technologies (RCMT) PT Raised to $45 at B.Riley
- AirJoule Technologies (AIRJ) PT Raised to $8 at B.Riley
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
